Cargando…
Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage
The advent of multi-cancer early detection (MCED) tests has the potential to revolutionise the diagnosis of cancer, improving patient outcomes through early diagnosis and increased use of curative therapies. The ongoing NHS-Galleri trial is evaluating an MCED test developed by GRAIL, and is using as...
Autores principales: | Callister, Matthew E. J., Crosbie, Emma J., Crosbie, Philip A. J., Robbins, Hilary A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575849/ https://www.ncbi.nlm.nih.gov/pubmed/37726480 http://dx.doi.org/10.1038/s41416-023-02434-4 |
Ejemplares similares
-
How should performance in EBUS mediastinal staging in lung cancer be measured?
por: Evison, Matthew, et al.
Publicado: (2016) -
Hollow Threats: Transnational Food and Beverage Companies’ Use of International Agreements to Fight Front-of-Pack Nutrition Labeling in Mexico and Beyond
por: Crosbie, Eric, et al.
Publicado: (2020) -
The argument for diversifying the NIH grant portfolio
por: Peifer, Mark
Publicado: (2017) -
Invited Perspective: An Argument for Changing the Reporting Units for Lead in Blood
por: Caravanos, Jack, et al.
Publicado: (2023) -
Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer
por: O’Mara, Tracy A., et al.
Publicado: (2020)